Co-Authors
This is a "connection" page, showing publications co-authored by Marco Ripa and Lorenzo Dagna.
Connection Strength
1.207
-
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021 Mar; 27(3):451-457.
Score: 0.227
-
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021 01; 133:104071.
Score: 0.226
-
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331.
Score: 0.220
-
Eosinophils from Physiology to Disease: A Comprehensive Review. Biomed Res Int. 2018; 2018:9095275.
Score: 0.188
-
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2021 May 17; 11(1):10699.
Score: 0.059
-
The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary Approach. J Clin Med. 2021 May 04; 10(9).
Score: 0.059
-
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021 Dec; 35(12):3631-3641.
Score: 0.058
-
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2020 12 04; 10(1):21291.
Score: 0.057
-
Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
Score: 0.057
-
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
Score: 0.055